Early Career Fellowships
A call to early career blood cancer researchers who have already obtained a PhD to advance their career as a researcher.
Introduction
An Early Career Advancement Fellowship is designed to enable the most talented early career blood cancer researchers who have already obtained a PhD and undertaken further research as a postdoc or equivalent, to transition towards independence as a researcher.
We want to continue to support the development of the most gifted early career researchers, so they can go on to become the next generation of blood cancer research leaders.
Key dates
Round open: Thursday 23rd April 2026
Deadline for submission of applications: 3pm on Thursday 9th July 2026
Interviews: Early December 2026
Applicants notified of outcomes: End December 2026
Grant amount
Grants will typically be awarded for up to three years' full time and we expect the awards to be in the region of £400,000-£450,000. The maximum budget will be £450,000.
We're aiming to fund three fellowships from our core budget for this round. In addition, we hope to award the second Langmuir Fellowship. This prestigious award has been made possible thanks to a generous gift from the Langmuir Family Foundation, and will be awarded to the highest ranked applicant in the field of myeloma.
Remit and eligibility
Applicants should be proposing to undertake a novel research project that is in line with our overarching strategic aim and with at least one of the three priority research themes from our research strategy:
- Prevention
- Early detection and predicting outcomes
- Treatment
The fellowship should provide the researcher with the leadership, career development and training opportunities needed for the applicant to reach the next stage in their career.
Fellows are permitted to undertake discovery or translational research, small scale clinical studies or research projects associated with ongoing clinical trials as part of a fellowship. These Fellowships are not designed to directly support the design or delivery of clinical trials.
We encourage applications from outstanding early career researchers who are dedicated to pursuing a career in blood cancer research, and who are aiming to transition towards independence with the support of this fellowship. To be eligible candidates will have had a maximum of six years’ full time equivalent active research experience since gaining their PhD. Allowances will be made for career breaks, COVID-19 impacts and clinical activity.
For more information on the full remit and eligibility criteria, head to page 2 in the application guidance document.
How to apply
All applications must be submitted via the new Blood Cancer UK Grants Portal. The form will be live from Thursday 30th April. Guidance on using the new portal will be provided. The full question set can be found in the guidance document below so you can begin preparing your application.
No applications will be accepted after the deadline. Applicants must submit their application ahead of this deadline leaving sufficient time for the required signatories to approve the application.
Assessment process
All proposals submitted for this call will be reviewed by external peer reviewers from relevant fields and people affected by blood cancer.
The application and associated reviews will be assessed and shortlisted by our Fellowships Committee and members of our Research Involvement Network. Shortlisted candidates will then be invited to interviews with members of our Fellowships Committee and Research Involvement Network.
More information on the assessment criteria can be found on pages 4-5 of the application guidance document.
Terms and conditions
Please make sure to read the application guidance document in full to ensure you have understood all of the requirements for this funding scheme.
Grants will be awarded in line with Blood Cancer UK’s Terms and Conditions.
Get in touch
If you have any queries regarding Early Career Fellowships, please contact [email protected].
The scheme's impact
Our Early Career Fellowships were relaunched in 2024-2025. The first awards were made in March 2025.
-
4 Awards made
-
£1,352,027 Total invested
-
29% Applicant success rate
Our research
Our £500 million investment in research since 1960 has helped transform treatments and taken us to the point where beating blood cancer is now in sight. Our researchers are working to finish the job.
More About ThisPreviously awarded Early Career Advancement Fellowships
- Using special cells in the bone marrow to help improve treatment of AML
- Understanding how leukaemia stem cells may help develop new treatments for AML
- Preventing and treating infections in patients with blood cancer following CAR-T cell therapy
- Unlocking new hope: developing new, effective treatments for people with myeloma and AML
Research newsletter
Subscribe to hear more about funding calls and the latest news from the Research team.
We will keep you updated about our work and the ways you can help, including campaigns and events. We promise to respect your privacy and we will never sell or swap your details.